MD SB572 | 2017 | Regular Session
Status
Spectrum: Slight Partisan Bill (Democrat 8-4)
Status: Engrossed on March 29 2017 - 50% progression, died in chamber
Action: 2017-04-10 - House Refuses to Recede
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on March 29 2017 - 50% progression, died in chamber
Action: 2017-04-10 - House Refuses to Recede
Text: Latest bill text (Engrossed) [PDF]
Summary
Authorizing a manufacturer of an investigational drug, biological product, or device to make available the investigational drug, biological product, or device to eligible patients; requiring a manufacturer of an investigational drug, biological product, or device to notify a specified patient and a specified health care provider of specified side effects or risks; requiring the Office of the Attorney General to develop an informed consent form that meets specified requirements; etc.
Title
Investigational Drugs, Biological Products, and Devices - Right to Try Act
Sponsors
Roll Calls
2017-04-03 - House - House Floor - Third Reading Passed (87-50) (Y: 87 N: 50 NV: 1 Abs: 3) [PASS]
2017-04-03 - House - House Floor - Motion Rules Suspend Two Readings Same Day (Delegate Glenn) Adopted (97-40) (Y: 97 N: 40 NV: 1 Abs: 3) [PASS]
2017-03-25 - Senate - Senate Floor - Third Reading Passed (46-0) (Y: 46 N: 0 NV: 0 Abs: 1) [PASS]
2017-04-03 - House - House Floor - Motion Rules Suspend Two Readings Same Day (Delegate Glenn) Adopted (97-40) (Y: 97 N: 40 NV: 1 Abs: 3) [PASS]
2017-03-25 - Senate - Senate Floor - Third Reading Passed (46-0) (Y: 46 N: 0 NV: 0 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2017-04-10 | House | House Refuses to Recede |
| 2017-04-10 | Senate | Senate Requests House Recede |
| 2017-04-10 | Senate | Senate Refuses to Concur - House Amendments |
| 2017-04-10 | House | Third Reading Passed with Amendments (87-50) |
| 2017-04-10 | House | Motion Rules Suspended two readings same day (Delegate Glenn) Adopted (97-40) |
| 2017-04-10 | House | Second Reading Passed with Amendments |
| 2017-04-10 | House | Special Order until later today (Delegate McMillan) Adopted |
| 2017-04-10 | House | Favorable with Amendments {886082/1 Report Adopted |
| 2017-04-10 | House | Favorable with Amendments Report by Health and Government Operations |
| 2017-04-04 | House | Rereferred to Health and Government Operations |
| 2017-03-30 | House | First Reading House Rules and Executive Nominations |
| 2017-03-29 | Senate | Third Reading Passed (46-0) |
| 2017-03-28 | Senate | Second Reading Passed with Amendments |
| 2017-03-28 | Senate | Floor Committee Amendment {327272/1 Adopted |
| 2017-03-28 | Senate | Floor Amendment {673726/1 (Senator Reilly) Adopted |
| 2017-03-24 | Senate | Special Order until 3/28 (Senator Reilly) Adopted |
| 2017-03-24 | Senate | Favorable with Amendments {957074/1 Report Adopted |
| 2017-03-24 | Senate | Favorable with Amendments Report by Finance |
| 2017-03-02 | Senate | Hearing 3/02 at 1:00 p.m. |
| 2017-02-02 | Senate | First Reading Finance |
Subjects
Committees and Commissions
Death
Disclosure
Diseases
Drugs
Equipment
Estates and Trusts
Health and Mental Hygiene, Department of
Health Insurance
Health Occupations
Hospices
Industry and Technology
Insurance - Health
Licenses
Medical Assistance
Medical Research
Patients
Physicians
Public Employees
Public Health
Public Officials
Death
Disclosure
Diseases
Drugs
Equipment
Estates and Trusts
Health and Mental Hygiene, Department of
Health Insurance
Health Occupations
Hospices
Industry and Technology
Insurance - Health
Licenses
Medical Assistance
Medical Research
Patients
Physicians
Public Employees
Public Health
Public Officials
